Back

Characteristics and prognosis of the catecholamine induced QT prolongation syndrome

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Primary arrhythmia syndromes - Device treatment Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Vincent Probst

University Hospital of Nantes, Nantes (France)

3 More presentations in this session

Presentation thumbnail
T-wave alternans poorly prognostic in primary prophylactic ICD patients: A prospective EU-CERT-ICD study
Doctor A. Pelli (Oulu, FI)
Abstract Slides Video
Presentation thumbnail
Three dimensional modelling of mutant Kir2.1 channel PIP2 interactions help stratify arrhythmia severity in Andersen Tawil syndrome type 1
Mrs L. Gutierrez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Catecholaminergic polymorphic ventricular tachycardia: risk modulators in patients treated with beta-blockers
Doctor D. Kukavica (Pavia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Primary arrhythmia syndromes - Device treatment

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation and sudden cardiac death risk – multifactorial phenotype
thumbnail
Congress Presentation
Novel ankyrin-B (ANK2) mutation and long QT syndrome
thumbnail
Congress Presentation
Static and dynamic abnormalities in electromechanical and autonomic cardiac function characterize the proarrhythmic substrate in the long-QT syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources